Results 171 to 180 of about 7,943,117 (301)

Pathogen-microenvironment-responsive and antioxidant-buffered propiconazole nanofungicide for safe and effective fungal disease control. [PDF]

J Nanobiotechnology
Shi X, Zhang Q, Chang X, Wang T, Tian F, Li X, Gu A, Liu X, Liu P.   +8 more
europepmc   +1 more source

The Control of Disease [PDF]

BMJ, 1939
openaire   +2 more sources

Molecular characterisation of human penile carcinoma and generation of paired epithelial primary cell lines

Molecular Oncology, EarlyView.
Generation of two normal and tumour (cancerous) paired human cell lines using an established tissue culture technique and their characterisation is described. Cell lines were characterised at cellular, protein, chromosome and gene expression levels and for HPV status.
Simon Broad, Mahmood Hachim, Tom Bertin, Karolina Penderecka, Rifat Hamoudi, Saif Khan, Rui Henrique, Natalie Bergmoser, Manit Arya, Kalle Sipila, Matteo Vietri Rudan, Asif Muneer, Aamir Ahmed   +12 more
wiley   +1 more source

Beyond Clinical Remission: Redefining Disease Control in Severe Asthma? [PDF]

Allergy Asthma Immunol Res
Kim Y, Song WJ.
europepmc   +1 more source

Cis‐regulatory and long noncoding RNA alterations in breast cancer – current insights, biomarker utility, and the critical need for functional validation

Molecular Oncology, EarlyView.
The noncoding region of the genome plays a key role in regulating gene expression, and mutations within these regions are capable of altering it. Researchers have identified multiple functional noncoding mutations associated with increased cancer risk in the genome of breast cancer patients.
Arnau Cuy Saqués, Aracele Martinez‐Mendez, John Crown, Alex Eustace   +3 more
wiley   +1 more source

Switching to the Dry Powder Inhaler: Disease Control with a Lower Carbon Footprint. [PDF]

Pulm Ther
Janson C, Hisinger-Mölkänen H, Tamasi L, Vartiainen V, Lehtimäki L.   +4 more
europepmc   +1 more source

Methylation biomarkers can distinguish pleural mesothelioma from healthy pleura and other pleural pathologies

Molecular Oncology, EarlyView.
We developed and validated a DNA methylation–based biomarker panel to distinguish pleural mesothelioma from other pleural conditions. Using the IMPRESS technology, we translated this panel into a clinically applicable assay. The resulting two classifier models demonstrated excellent performance, achieving high AUC values and strong diagnostic accuracy.
Janah Vandenhoeck, Nele De Meulenaere, Thomas Vanpoucke, Joe Ibrahim, Dieter Peeters, Suresh Krishan Yogeswaran, Wen Wen, Paul Van Schil, Jeroen M. H. Hendriks, Jo Raskin, Jan van Meerbeeck, Guy Van Camp, Ken Op de Beeck   +12 more
wiley   +1 more source

Lyme disease control 2.0: Advances and opportunities coming with Lyme disease vaccine VLA15. [PDF]

PLoS Pathog
Hajdusek O, Brangulis K, Robbertse L, Ghosh R, Carlo DD, Perner J.   +5 more
europepmc   +1 more source

Strength through diversity: how cancers thrive when clones cooperate

Molecular Oncology, EarlyView.
Intratumor heterogeneity can offer direct benefits to the tumor through cooperation between different clones. In this review, Kuiken et al. discuss existing evidence for clonal cooperativity to identify overarching principles, and highlight how novel technological developments could address remaining open questions.
Marije C. Kuiken, Maartje Witsen, Emile E. Voest, Krijn K. Dijkstra   +3 more
wiley   +1 more source

Bacteriophages as Agents for Plant Disease Control: Where Are We After a Century? [PDF]

Viruses
Choudhary M, Bankole IA, McDuffee ST, Parajuli A, Poudel M, Balogh B, Paret ML, Jones JB.   +7 more
europepmc   +1 more source